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A B S T R A C T
Subependymal nodular heterotopia (SNH) is a cortical development malformation that is commonly
associated with medically resistant epilepsy. Cases of SNH are challenging to treat surgically because
there are typically multiple nodules, which may be involved in epileptogenesis. Moreover, dual pathology
may exist in these patients. Here, we present a case with unilateral subependymal heterotopic nodules
associated with ipsilateral hippocampal atrophy. Invasive and non-invasive work-ups revealed that the
hippocampus was the actual ictal onset zone and that the SNH was not involved. An anterior temporal
lobectomy was carried out, and postoperative seizure outcome was class Ia at the end of 2 years. The case
demonstrates that SNH may not play a major role in patients with dual pathology. However, direct
electroencephalography (EEG) recording from areas of SNH and other possible epileptogenic regions is
indispensable in defining the ictal onset zone and avoiding poor surgical outcomes.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Subependymal nodular heterotopia (SNH) is a cortical devel-
opment malformation that is close to the periventricular germinal
matrix and made up of round, nodular masses of normal neuroglia
that lack laminar organisation.2,5,6,15 Regardless of whether SNH
are bilateral, symmetric or unilateral, the main clinical issue is
medically refractory focal epilepsy. It is proposed that epilepsy in
SNH patients is the result of complex interactions between
heterotopic nodules and adjacent archicortical and neocortical
areas. Although there are conflicting results in terms of surgical
outcome, epilepsy surgery can be favourable after a careful
assessment of seizure-generating structures and after establishing
a rationale for surgical approach.12,14,18,19 Here, we present a
surgically treated patient with drug resistant focal epilepsy whose
MRI was consistent with unilateral SNH and ipsilateral hippocam-
pal atrophy.
2. Case description
A twenty-seven-year-old woman with a history of intractable
epilepsy was admitted for pre-surgical evaluation. Her seizures* Corresponding author at: Pamukkale University Medical School, Kınıklı kampus
B-173, Denizli, Turkey. Tel.: +90 258 4440728 5682.
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doi:10.1016/j.seizure.2011.11.002started when she was 10 months old and occurred 2–3 times a
month, lasting less than 2 min. Her parents described her daytime
seizures as ‘‘a staring event where she does not respond but gulps
repeatedly and picks at her clothes’’. Phenytoin and carbamazepine
partially controlled her seizures until she was 9 years old.
Following a secondarily generalised tonic–clonic seizure at the
age of 12 years she was put on valproic acid, but different anti-
epileptic drug combinations did not effectively control the
seizures. At the time of admission she had 1–2 seizures per week,
despite a combination of valproic acid, lamotrigine and levetir-
acetam. She did not have a history of prenatal problems but was
delivered by forceps. Early developmental milestones were not
delayed. She had a prolonged febrile convulsion (more than
15 min) at 16 months. She was able to complete 8 years of
compulsory education but could not attend high school because of
frequent seizures. She was unemployed and did not have a driving
licence. Her family history was unremarkable for epilepsy.
The scalp video-EEG demonstrated interictal right frontotem-
poral epileptiform discharges. She could clearly define her auras,
which were primarily feelings of déjà vu and sometimes fear. In
video-EEG monitoring unit 3 habitual seizures were recorded, and
they began with staring, loss of responsiveness and swallowing,
followed by incoherent speech, which progressed to dystonic
posturing of the left arm and a postictal confusion period. Her
seizures generally lasted 8–10 min. The ictal video-EEG docu-
mented rhythmic delta activity in the right anterior temporal
electrodes prior to the clinical seizure. The cranial MRI showedvier Ltd. All rights reserved.
Fig. 1. T2-weighted coronal sections showing multiple nodules consisting of grey
matter along the paratrigonal region of the right lateral ventricle (arrow). The
ipsilateral side shows volume loss in the hippocampus and parahippocampal gyrus
and a significant signal change.
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matter located along the paratrigonal region of the right lateral
ventricle without an extension to the overlying cortex. Addition-
ally, hippocampal atrophy with loss of digitations and T2 signal
change ipsilateral to the SNH was evident (Fig. 1). She had no
agenesis or hypogenesis of the corpus callosum, malformations in
the cerebellum, basal ganglia or thalamus and no extension to the
overlying cortex.
Magnetic resonance spectroscopy showed reduced N-acetyl-
aspartate (NAA) concentration and NAA/creatine in the right
hippocampus. The fluorine-18 (F-18) fluorodeoxyglucose positron
emission tomography (FDG-PET) scan revealed decreased uptake in
the right temporal region compared to the left. Neuropsychological
testing (NPT) revealed moderate attention and verbal memory recall
deficits, which were consistent with her mildly reduced IQ and mild
deficit in abstracting capacity. The Bender–Gestalt test assessing
visuomotor and visuospatial abilities was normal. Surgical planning
was performed on the basis of the pre-surgical non-invasive work-
up designating the right temporal lobe as the possible ictal onset
zone. However, it was not possible to estimate the extent of
heterotopic nodules that contributed to the onset of seizures.
Therefore, in the multidisciplinary pre-surgical conference, we
decided to perform an invasive work-up. A subdural grid covering
the right temporal neocortex was implanted via standard cranioto-
my under general anaesthesia, and two depth electrodes were
stereotactically implanted in the hippocampus and the SNH.
Invasive ictal recordings revealed that habitual seizures started
from the right hippocampus, and the heterotopic nodules were
silent throughout the ictal period (Figs. 2 and 3). Furthermore,
electrocortical stimulation of the hippocampus via depth electrodes
evoked a typical aura of déjà vu. A standard anterior temporal
lobectomy with amygdalohippocampectomy was carried out, and
the nodules were spared. Neuropathological examination of the
surgical specimen revealed characteristic patterns of neuronal loss
in the CA1 region of the hippocampus.
In the early postoperative period, she was on combination
therapy of valproic acid (1250 mg), lamotrigine (200 mg) and
levetiracetam (1000 mg) daily. Post-operative seizure outcome
was excellent at the end of the first year and allowed her to quit
valproic acid and reduce the lamotrigine dosage. At her last follow-up visit, she was on 1000 mg of levetiracetam and 100 mg of
lamotrigine daily and had been seizure-free for 2 years. Post-
operative NPT revealed that her mild memory deficits were
unchanged.
3. Discussion
Subependymal heterotopia is a neuronal migration disorder
characterised by nodules of neuron clusters due to migration arrest
or failure of neuroblasts to undergo apoptosis.4,9 The nodules may
appear in the subpial, subcortical or subependymal regions. The
subependymal nodules are the most common form of grey matter
heterotopias, which are located close together and form irregular
lumps adjacent to the lateral ventricles, bilaterally or unilateral-
ly.13 Radial glial fibres act as guides for migrating neurons; direct
damage to these fibres and deficiency of adhesion molecules
essential for migrating neuroblasts may lead to mislocalised
neuronal clustering. Neuroimaging with high-resolution MRI can
clearly delineate subependymal heterotopias most frequently
located in the paratrigonal region and frontal horns of the lateral
ventricles.3,21
Independent of being uni- or bilateral, the main problem
associated with SNH is epilepsy, which can present as both partial
and generalised seizures. Moreover, SNH can also be observed in
patients without epilepsy; therefore, it is not clear whether
heterotopic nodules are the direct cause of epilepsy or a marker
of a more widespread abnormality.13,16,21 SNH can also be a
component of dual pathology. Hippocampal sclerosis is associated
with various types of cortical dysgenesis, most commonly with
nodular heterotopia.13 In a series of 10 patients, two patients had
unilateral hippocampal abnormalities and ipsilateral SNH.13 Tassi
et al.19 reported that one of those patients was seizure-free following
a temporal corticectomy with partial hippocampectomy. However,
the hippocampal tissue did not show typical signs of hippocampal
sclerosis but did have reactive gliosis.19 Raymond et al.13 reported
that two patients with concomitant hippocampal sclerosis achieved
seizure freedom or improved seizure control after standard anterior
temporal lobectomies. Dubeau et al.7 reported on a series of 33
patients with SNH; 2 of the seven patients undergoing anterior
temporal lobectomy achieved seizure freedom, but the others did
not improve at all. A report by Li et al.12 with 10 patients showed that
one of them was similar to our case with unilateral SNH and
hippocampal sclerosis and was class II post-operatively. These
studies have suggested that heterotopic nodules may have variable
epileptogenicity. Unfortunately, it is not possible to make absolute
conclusions because some of the cases were not studied with
invasive monitoring to determine seizure origin. However, several
studies utilising invasive monitoring of heterotopic nodules
revealed that most of them experience epileptic activity of their
own accord at seizure onset, which is synchronous with the
overlying neocortex or ipsilateral hippocampus.1,11,19 Moreover,
interictal recordings also showed that these neuron clusters are
capable of generating their own epileptic activity.1,11,19 Although
these studies demonstrate connectivity between nodules, overlying
cortex and distant cortical structures, the role of heterotopia in
seizure generation is not clear. Functional imaging studies during
EEG monitoring showed that seizures were generated by the
overlying cortex but not the heterotopia.10,20 Nevertheless, the
connections between nodules and other cortical structures may be
involved in amplification and synchronisation of epileptic activity,
and these roles may explain the widespread epileptogenic networks
in these patients.
In our case, an aura suggesting mesolimbic temporal origin and
unilateral interictal temporal epileptic abnormalities with findings
of unilateral SNH led to further investigations. A PET scan and MR
spectroscopy revealed an ipsilateral hippocampal abnormality
Figs. 2 and 3. The first two channels were recorded from depth electrodes implanted in the SNH and the 5 middle channels represent depth electrodes in the right
hippocampus. Other channels were recorded from grid electrodes on the anterior temporal neocortex. The patient was asked to press a button at seizure onset, and 2–3 s later
rhythmic, fast activity appeared that evolved to spike discharges The SNH were silent throughout the ictal period. Epileptic discharges spread to temporal neocortical areas.
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monitoring that verified the non-invasive work-up and clinical
features and designated the right hippocampus as the epilepto-
genic zone. Furthermore, electrocortical stimulation of the
hippocampus led to a habitual aura whereas PNH stimulation
did not cause any clinical sign or symptom. Our surgical strategy
was based on the congruence of the invasive and non-invasive
evaluations, and the patient’s post-operative outcome indicated
that a crucial region of the epileptogenic zone was removed.
Moreover, in the long-term follow-up, she will probably experi-
ence a recurrence of seizures. For refractory mesial temporal lobe
epilepsy with hippocampal sclerosis, there is a high risk of seizure
recurrence after surgery, irrespective of pathology.8,17 Refractory
epilepsy is a widespread pathology whether the underlying cause
is hippocampal sclerosis or cortical development malformations;
therefore, it is difficult to say that we can totally cure refractoryepilepsy through surgery. We do not know whether our patient has
a cortical abnormality in the overlying cortex or whether there are
other connections with distant cortical structures that may lead to
seizure recurrence. So far, it is obvious that the outcome is
favourable, as a result of either removal of the pacemaker or
disconnection.
In conclusion, in cases with unilateral SNH, the best predictor of
the surgical outcome is the determination of the ictal onset zone.
Therefore, invasive monitoring of possible epileptogenic zones
provides the best scientific analysis of the ictus and is the gold
standard in planning surgical strategies. However, SNH may not
necessarily play a major role in the epileptogenicity of patients
with dual pathology. Therefore, because of the variability of the
heterotopic nodule epileptogenicity, direct recording of SNH in
addition to other possible cortical areas is indispensable in defining
the ictal onset zone and avoiding poor surgical outcomes.
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